Company Announcement

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Revised Press Release For: "Reliable Drug" Recall of all Compounded Medications Due to a Potential for Mislabeling and Lack of Quality Assurance

For Immediate Release

March 25, 2016



Reliable Drug


Natalia Mazina


Reliable Drug Pharmacy is voluntarily recalling all unexpired lots of compounded products due to concern of lack of quality assurance and potential mislabeling. All unexpired lots are subject to the recall. All recalled products were distributed to patients and veterinarians within California. A few products were shipped to Hawaii, New Mexico, and Michigan.

All recalled products have a label that includes Reliable Drug name or Reliable Compounding Pharmacy and expiration date. If unsure, Customers can call the pharmacy to determine the expiration date. This recall impacts all compounded products distributed between 03/24/2015 and 03/24/2016.

The recall was issued after a series of onsite inspections by the FDA. Out of an abundance of caution, Reliable Drug is voluntarily recalling all compounded product within expiry.

Customers that have recalled product should immediately stop using it and contact the pharmacy to arrange for the return of unused product. Customers should contact their physician or health care provider if they have experienced any problems that may be related to taking or using these products.

Customers with questions regarding this recall can contact Reliable Drug Pharmacy by phone (415) 664-8800 Monday through Friday 10 am - 6:30 pm and Saturday 9 am - 12:30 pm, or email its media representative.

Adverse reactions or quality problems experiences with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Reliable Drug Pharmacy deeply regrets any disruption that this voluntary recall and temporary suspension of compounding services have on its Customers, but notes that safety and quality are its primary concerns.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration and California State Board of Pharmacy.

Original Press Release

Related FDA Announcement


Page Last Updated: 03/13/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English